AI-Driven Multi-Omics Biomarker Discovery for Drug Efficacy and Toxicity Prediction in Metabolic Diseases
Investigating the Toxicological Impact of Synthetic Cannabinoid Metabolites on Biological Systems
Mechanistic Studies of Antifibrotic Therapies in Metabolic dysfunction-associated steatohepatitis (MASH)
Development of novel therapeutic modalities for central nervous system inflammatory diseases via modulation of CNS lymphatic function
Biomarker discovery for adverse effects of prostaglandin therapy in tears of normal-tension glaucoma patients
